Cargando…

Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome

BACKGROUND: In previous pilot work we demonstrated that a novel automated signal analysis tool could accurately identify successful ablation sites during Wolff-Parkinson-White (WPW) ablation at a single center. OBJECTIVE: We sought to validate and refine this signal analysis tool in a larger multi-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceresnak, Scott R., Pass, Robert H., Dubin, Anne M., Yang, Lingyao, Motonaga, Kara S., Hedlin, Haley, Avasarala, Kishor, Trela, Anthony, McElhinney, Doff B., Janson, Christopher, Nappo, Lynn, Ling, Xuefeng B., Gates, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594583/
https://www.ncbi.nlm.nih.gov/pubmed/31242221
http://dx.doi.org/10.1371/journal.pone.0217282
_version_ 1783430257441767424
author Ceresnak, Scott R.
Pass, Robert H.
Dubin, Anne M.
Yang, Lingyao
Motonaga, Kara S.
Hedlin, Haley
Avasarala, Kishor
Trela, Anthony
McElhinney, Doff B.
Janson, Christopher
Nappo, Lynn
Ling, Xuefeng B.
Gates, Gregory J.
author_facet Ceresnak, Scott R.
Pass, Robert H.
Dubin, Anne M.
Yang, Lingyao
Motonaga, Kara S.
Hedlin, Haley
Avasarala, Kishor
Trela, Anthony
McElhinney, Doff B.
Janson, Christopher
Nappo, Lynn
Ling, Xuefeng B.
Gates, Gregory J.
author_sort Ceresnak, Scott R.
collection PubMed
description BACKGROUND: In previous pilot work we demonstrated that a novel automated signal analysis tool could accurately identify successful ablation sites during Wolff-Parkinson-White (WPW) ablation at a single center. OBJECTIVE: We sought to validate and refine this signal analysis tool in a larger multi-center cohort of children with WPW. METHODS: A retrospective review was performed of signal data from children with WPW who underwent ablation at two pediatric arrhythmia centers from 2008–2015. All patients with WPW ≤ 21 years who underwent invasive electrophysiology study and ablation with ablation signals available for review were included. Signals were excluded if temperature or power delivery was inadequate or lesion time was < 5 seconds. Ablation lesions were reviewed for each patient. Signals were classified as successful if there was loss of antegrade and retrograde accessory pathway (AP) conduction or unsuccessful if ablation did not eliminate AP conduction. Custom signal analysis software analyzed intracardiac electrograms for amplitudes, high and low frequency components, integrated area, and signal timing components to create a signal score. We validated the previously published signal score threshold 3.1 in this larger, more diverse cohort and explored additional scoring options. Logistic regression with lasso regularization using Youden’s index criterion and a cost-benefit criterion to identify thresholds was considered as a refinement to this score. RESULTS: 347 signals (141 successful, 206 unsuccessful) in 144 pts were analyzed [mean age 13.2 ± 3.9 years, 96 (67%) male, 66 (45%) left sided APs]. The software correctly identified the signals as successful or unsuccessful in 276/347 (80%) at a threshold of 3.1. The performance of other thresholds did not significantly improve the predictive ability. A signal score threshold of 3.1 provided the following diagnostic accuracy for distinguishing a successful from unsuccessful signal: sensitivity 83%, specificity 77%, PPV 71%, NPV 87%. CONCLUSIONS: An automated signal analysis software tool reliably distinguished successful versus unsuccessful ablation electrograms in children with WPW when validated in a large, diverse cohort. Refining the tools using an alternative threshold and statistical method did not improve the original signal score at a threshold of 3.1. This software was effective across two centers and multiple operators and may be an effective tool for ablation of WPW.
format Online
Article
Text
id pubmed-6594583
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65945832019-07-05 Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome Ceresnak, Scott R. Pass, Robert H. Dubin, Anne M. Yang, Lingyao Motonaga, Kara S. Hedlin, Haley Avasarala, Kishor Trela, Anthony McElhinney, Doff B. Janson, Christopher Nappo, Lynn Ling, Xuefeng B. Gates, Gregory J. PLoS One Research Article BACKGROUND: In previous pilot work we demonstrated that a novel automated signal analysis tool could accurately identify successful ablation sites during Wolff-Parkinson-White (WPW) ablation at a single center. OBJECTIVE: We sought to validate and refine this signal analysis tool in a larger multi-center cohort of children with WPW. METHODS: A retrospective review was performed of signal data from children with WPW who underwent ablation at two pediatric arrhythmia centers from 2008–2015. All patients with WPW ≤ 21 years who underwent invasive electrophysiology study and ablation with ablation signals available for review were included. Signals were excluded if temperature or power delivery was inadequate or lesion time was < 5 seconds. Ablation lesions were reviewed for each patient. Signals were classified as successful if there was loss of antegrade and retrograde accessory pathway (AP) conduction or unsuccessful if ablation did not eliminate AP conduction. Custom signal analysis software analyzed intracardiac electrograms for amplitudes, high and low frequency components, integrated area, and signal timing components to create a signal score. We validated the previously published signal score threshold 3.1 in this larger, more diverse cohort and explored additional scoring options. Logistic regression with lasso regularization using Youden’s index criterion and a cost-benefit criterion to identify thresholds was considered as a refinement to this score. RESULTS: 347 signals (141 successful, 206 unsuccessful) in 144 pts were analyzed [mean age 13.2 ± 3.9 years, 96 (67%) male, 66 (45%) left sided APs]. The software correctly identified the signals as successful or unsuccessful in 276/347 (80%) at a threshold of 3.1. The performance of other thresholds did not significantly improve the predictive ability. A signal score threshold of 3.1 provided the following diagnostic accuracy for distinguishing a successful from unsuccessful signal: sensitivity 83%, specificity 77%, PPV 71%, NPV 87%. CONCLUSIONS: An automated signal analysis software tool reliably distinguished successful versus unsuccessful ablation electrograms in children with WPW when validated in a large, diverse cohort. Refining the tools using an alternative threshold and statistical method did not improve the original signal score at a threshold of 3.1. This software was effective across two centers and multiple operators and may be an effective tool for ablation of WPW. Public Library of Science 2019-06-26 /pmc/articles/PMC6594583/ /pubmed/31242221 http://dx.doi.org/10.1371/journal.pone.0217282 Text en © 2019 Ceresnak et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ceresnak, Scott R.
Pass, Robert H.
Dubin, Anne M.
Yang, Lingyao
Motonaga, Kara S.
Hedlin, Haley
Avasarala, Kishor
Trela, Anthony
McElhinney, Doff B.
Janson, Christopher
Nappo, Lynn
Ling, Xuefeng B.
Gates, Gregory J.
Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome
title Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome
title_full Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome
title_fullStr Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome
title_full_unstemmed Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome
title_short Validation of a novel automated signal analysis tool for ablation of Wolff-Parkinson-White Syndrome
title_sort validation of a novel automated signal analysis tool for ablation of wolff-parkinson-white syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594583/
https://www.ncbi.nlm.nih.gov/pubmed/31242221
http://dx.doi.org/10.1371/journal.pone.0217282
work_keys_str_mv AT ceresnakscottr validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT passroberth validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT dubinannem validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT yanglingyao validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT motonagakaras validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT hedlinhaley validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT avasaralakishor validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT trelaanthony validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT mcelhinneydoffb validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT jansonchristopher validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT nappolynn validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT lingxuefengb validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome
AT gatesgregoryj validationofanovelautomatedsignalanalysistoolforablationofwolffparkinsonwhitesyndrome